BioSpace News Archive

Business

Agios to Webcast Conference Call of Third Quarter 2019 Financial Results on October 31, 2019

Agios Pharmaceuticals, Inc. announced that the company will host a conference call and live webcast on Thursday, October 31, 2019 at 8:00 a.m. ET to report its third quarter 2019 financial results and other business highlights..

October 17, 2019
·
1 min read
Business

NeuroMetrix Reports Q3 2019 Financial Results

NeuroMetrix, Inc. reported financial and business highlights for the quarter ended September 30, 2019.

October 17, 2019
·
6 min read
Pharm Country

Arvinas to Present Initial Data from Ongoing Clinical Trials and a Pipeline Update at the 2nd Targeted Protein Degradation Summit

Arvinas Inc.,, a biotechnology company creating a new class of drugs based on targeted protein degradation, announced it will be participating in multiple sessions of the 2nd Targeted Protein Degradation Summit.

October 17, 2019
·
5 min read
Business

Centene, Walgreens and RxAdvance Announce Partnership to Provide Innovative Pharmacy Management Model

Centene Corporation, Walgreens and RxAdvance announced a strategic partnership to introduce an innovative model for pharmacy management that aims to increase transparency, enhance customer experience and ultimately result in better health outcomes at lower costs.

October 17, 2019
·
7 min read
Drug Development

QED and Parent Company BridgeBio Announce Preclinical Data Supporting Tolerability and Activity of Low-dose Infigratinib in Treating Achondroplasia

Infigratinib showed improvements in nine measures of bone development in the Fgfr3[Y367C/+] mouse model of achondroplasia at a low dose

October 17, 2019
·
8 min read
Business

Allergan to Report Third Quarter 2019 Financial Results

Allergan plc announced it will release third quarter 2019 financial results on Tuesday, November 5, 2019, prior to the open of U.S.

October 17, 2019
·
2 min read
Pharm Country

RenalytixAI Partners with Capital District Physicians’ Health Plan, Inc. on KidneyIntelX™

Effective October 16, KidneyIntelX will be covered for reimbursement for qualified members

October 17, 2019
·
4 min read
Drug Development

Bimekizumab Phase 3 Psoriasis Study Meets All Endpoints, Achieving Significantly Greater Efficacy Versus Placebo and Ustekinumab

The Phase 3 BE VIVID study evaluating the efficacy and safety of bimekizumab in adults with moderate-to-severe chronic plaque psoriasis met all primary and ranked secondary endpointsi

October 17, 2019
·
8 min read
Pharm Country

Palatin Presents On Pl8177 Oral Colon Delivery Formulation For Ulcerative Colitis At The 7Th CPC Symposium On Peptide Therapeutics

Dr. Dodd was invited by symposium organizers to speak about the challenges of peptide drug development.

October 17, 2019
·
2 min read
BioCapital

REGENXBIO Announces Presentations at the European Society of Gene & Cell Therapy 27th Annual Congress

REGENXBIO Inc. announced the presentation of two posters at the European Society of Gene & Cell Therapy 27th Annual Congress in Barcelona, Spain, taking place from October 22 to 25, 2019.

October 17, 2019
·
1 min read